SCHEMBL872053

SCHEMBL872053

O=C(OC(CO)CO)c1ccccc1

nearest known ligand 0.59

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TSHR P16473 2/20 0.59
TP53 P04637 1/20 0.59
LMNA P02545 4/20 0.52
F2 P00734 1/20 0.52
PRKCA P17252 1/20 0.51
ALDH1A1 P00352 2/20 0.50
KMT2A Q03164 2/20 0.49
MEN1 O00255 1/20 0.49
TDP1 Q9NUW8 2/20 0.48
PDCD1 Q15116 1/20 0.47
CD274 Q9NZQ7 1/20 0.47
SLC6A3 Q01959 2/20 0.47
MAPK1 P28482 1/20 0.47
HIF1A Q16665 1/20 0.47
SLC6A2 P23975 1/20 0.47
ESR1 P03372 1/20 0.46
ESR2 Q92731 1/20 0.46
CYP2D6 P10635 2/20 0.45
NPC1 O15118 2/20 0.45
RAB9A P51151 2/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10062937 0.89 TSHR (0.52) TSHRTP53LMNAF2PRKCA
SCHEMBL3417176 0.87 MEN1 (0.60) TSHRTP53LMNAF2PRKCA
SCHEMBL3181495 0.87 ALDH1A1 (0.61) TSHRTP53LMNAF2PRKCA
SCHEMBL29964300 0.87 ALDH1A1 (0.61) TSHRTP53LMNAF2PRKCA
SCHEMBL11575408 0.86 TSHR (0.48) TSHRTP53PRKCAALDH1A1KMT2A
SCHEMBL23521287 0.86 MEN1 (0.52) TSHRTP53LMNAF2PRKCA
SCHEMBL18279594 0.86 TSHR (0.49) TSHRTP53LMNAF2PRKCA
SCHEMBL2698220 0.86 TSHR (0.53) TSHRTP53LMNAF2PRKCA
SCHEMBL2698217 0.86 TSHR (0.53) TSHRTP53LMNAF2PRKCA
SCHEMBL18279593 0.86 TSHR (0.49) TSHRTP53LMNAF2PRKCA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 98 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-115707703-A Nitrosamine compound, preparation method thereof, application of nitrosamine compound in detection of valnemulin tartrate bulk drug or preparation and detection method 山东威智中科药业有限公司 2023-02-21 CN claimed
US-20220106465-A1 COMPOSITIONS SUITABLE FOR MANUFACTURING POLYETHYLENE FOAM, AND ARTICLES THEREOF DOW GLOBAL TECHNOLOGIES LLC (US) 2022-04-07 US claimed
EP-2561011-B1 THERMOPLASTIC AND/OR ELASTOMERIC COMPOSITE MATERIAL BASED ON CARBON NANOTUBES AND GRAPHENES ARKEMA FRANCE (FR) 2016-01-06 EP claimed
US-8808580-B2 Thermoplastic and/or elastomeric composite based on carbon nanotubes and graphenes ARKEMA FRANCE (FR) 2014-08-19 US claimed
US-20110260116-A1 THERMOPLASTIC AND/OR ELASTOMERIC COMPOSITE BASED ON CARBON NANOTUBES AND GRAPHENES ARKEMA FRANCE (FR) 2011-10-27 US claimed
US-20110201731-A1 METHOD FOR PREPARING A THERMOPLASTIC COMPOSITE MATERIAL CONTAINING NANOTUBES PARTICULARLY CARBON NANOTUBES ARKEMA FRANCE (FR) 2011-08-18 US claimed
US-20090257968-A1 Gels containing anionic surfactants and coupling agents WALTON RICHARD 2009-10-15 US claimed
US-20050220832-A1 Gels containing metallic soaps and coupling agents WALTON RICHARD 2005-10-06 US claimed
CN-122075353-A Essence composition with skin whitening effect 2026-05-26 CN disclosed
US-12624482-B2 Nonwoven fabrics comprising polylactic acid and surface-treated calcium carbonate OMYA INTERNATIONAL AG (CH) 2026-05-12 US disclosed
EP-4696689-A1 SALT FORM AND CRYSTAL FORM OF CHIRAL HETEROCYCLIC COMPOUND HAVING HEDGEHOG PATHWAY ANTAGONIST ACTIVITY Suzhou Kintor Pharmaceuticals, Inc. (CN) 2026-02-18 EP disclosed
EP-4097283-B1 NONWOVEN FABRICS COMPRISING POLYLACTIC ACID AND SURFACE-TREATED CALCIUM CARBONATE OMYA INT AG (CH) 2025-06-25 EP disclosed
CN-115803381-B Aliphatic polyester resin composition and use thereof 株式会社钟化 2024-09-24 CN disclosed
CN-118556095-A Modified aliphatic polyester resin, and composition or molded article thereof 株式会社钟化 2024-08-27 CN disclosed
US-20050220832-A1 Gels containing metallic soaps and coupling agents WALTON RICHARD 2005-10-06 US disclosed
WO-2004073698-A1 THERAPEUTIC USE OF ACYL GLYCEROLS AND THE NITROGEN- AND SULPHUR-CONTAINING ANALOGUES THEROF GENFIT (FR) 2004-09-02 WO disclosed
WO-2004069241-A1 THERAPEUTIC USE OF ACYLGLYCEROLS AND THE NITROGEN- AND SULPHUR-CONTAINING ANALOGUES THEREOF GENFIT (FR) 2004-08-19 WO disclosed
US-4707405-A COPPER OR SILVER ON GLASS, RESIN PPG INDUSTRIES, INC. (US) 1987-11-17 US disclosed
US-4259225-A STORAGE STABILITY DAINIPPON INK & CHEMICALS, INC. (JP) 1981-03-31 US disclosed
US-4134868-A Aromatic carboxylic acid ester stabilizers for PVC resins ARGUS CHEMICAL CORPORATION (US) 1979-01-16 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050220832-A1 Gels containing metallic soaps and coupling agents MSN, S100P, STMN1 TSHR 4782/4885TP53 419/4885LMNA 4558/4885
US-12624482-B2 Nonwoven fabrics comprising polylactic acid and surface-treated calcium carbonate STIM1, CA2, CACNA2D4 TSHR 4718/4885TP53 1702/4885LMNA 1201/4885
US-20090257968-A1 Gels containing anionic surfactants and coupling agents RAB5IF, ANXA4, ANXA11 TSHR 4698/4885TP53 899/4885LMNA 2562/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.